€3.45
0.00% day before yesterday
Madrid, Dec 27, 05:35 pm CET
ISIN
ES0134950F36
Symbol
FAE
Sector
Industry

Faes Farma SAReg Stock price

€3.45
-0.04 1.15% 1M
-0.14 3.90% 6M
+0.29 9.18% YTD
+0.26 8.15% 1Y
+0.20 6.28% 3Y
-1.67 32.62% 5Y
+1.79 108.12% 10Y
Madrid, Closing price Fri, Dec 27 2024
+0.00 0.00%
ISIN
ES0134950F36
Symbol
FAE
Sector
Industry

Key metrics

Market capitalization €1.07b
Enterprise Value €1.01b
P/E (TTM) P/E ratio 11.04
EV/FCF (TTM) EV/FCF 19.76
EV/Sales (TTM) EV/Sales 2.13
P/S ratio (TTM) P/S ratio 2.26
P/B ratio (TTM) P/B ratio 1.57
Dividend yield 4.55%
Last dividend (FY24) €0.16
Revenue growth (TTM) Revenue growth 7.24%
Revenue (TTM) Revenue €476.11m
EBIT (operating result TTM) EBIT €104.15m
Free Cash Flow (TTM) Free Cash Flow €51.21m
EPS (TTM) EPS €0.31
P/E forward 12.11
P/S forward 2.21
EV/Sales forward 2.09
Show more

Is Faes Farma SAReg a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Faes Farma SAReg Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Faes Farma SAReg forecast:

1x Hold
50%
1x Sell
50%

Analyst Opinions

2 Analysts have issued a Faes Farma SAReg forecast:

Hold
50%
Sell
50%

Financial data from Faes Farma SAReg

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
476 476
7% 7%
100%
- Direct Costs 280 280
4% 4%
59%
196 196
12% 12%
41%
- Selling and Administrative Expenses 84 84
9% 9%
18%
- Research and Development Expense - -
-
-
124 124
9% 9%
26%
- Depreciation and Amortization 20 20
2% 2%
4%
EBIT (Operating Income) EBIT 104 104
11% 11%
22%
Net Profit 97 97
9% 9%
20%

In millions EUR.

Don't miss a Thing! We will send you all news about Faes Farma SAReg directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Faes Farma SA operates as a pharmaceutical company. It engages in manufacturing and sale of chemical and pharmaceutical products, as well as the acquisition, purchase, sale, investment, holding, administration, management, negotiation and leasing of companies, of transferable and immovable securities, patents, trademarks and registrations and social participations. The company was founded in 1933 and is headquartered in Leioa, Spain.

Head office Spain
CEO Eduardo Cuadra
Founded 1933
Website faesfarma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today